What is GE HealthCare?
Medical imaging and healthcare technology company with $20.6B 2025 revenue scale and public-market buying capacity.
- Category
- Medical imaging and healthcare technology
- Headquarters
- Chicago, IL
- Founded
- 2023 public company
- Employees
- 53,000+
- Total funding
- Public company; no VC funding
- Status
- Nasdaq: GEHC; Public company
What is GE HealthCare?
GE HealthCare is a public medical imaging and healthcare technology company headquartered in Chicago, IL. GE HealthCare reported 2025 revenues of $20.6 billion, up 4.8%, with about 1 billion patients served annually and roughly 5 million installed units globally.
GE HealthCare operates in medical imaging and healthcare technology with a portfolio that includes MRI and CT systems, Ultrasound, Pharmaceutical diagnostics, Patient care solutions. GE HealthCare reported 2025 revenues of $20.6 billion, up 4.8%, with about 1 billion patients served annually and roughly 5 million installed units globally. The company employs about 53,000+ and trades as Nasdaq: GEHC, so its buying motion looks like a regulated enterprise account rather than a startup account.
Its scale comes from clinically regulated products, payer or provider relationships, recurring consumables or services, intellectual property, manufacturing quality systems, and commercial access. Customers and partners evaluate GE HealthCare through clinical outcomes, regulatory execution, supply reliability, reimbursement, data security, and total cost of care.
For sellers, GE HealthCare is a multi-stakeholder account. Procurement, finance, clinical, quality, regulatory, legal, privacy, security, IT, operations, commercial, and business-unit leaders can all influence vendor approval. Strong pitches connect directly to patient impact, compliance, revenue capture, operating leverage, risk reduction, uptime, or measurable productivity.
What does GE HealthCare offer?
GE HealthCare offers products and services across MRI and CT systems, Ultrasound, Pharmaceutical diagnostics, Patient care solutions and related healthcare workflows.
- MRI and CT systems· Imaging
- Ultrasound· Imaging
- Pharmaceutical diagnostics· Contrast and tracers
- Patient care solutions· Monitoring
- Advanced Visualization Solutions· Software
- Service and installed-base support· Services
How does GE HealthCare make money?
GE HealthCare earns revenue through regulated healthcare products, services, recurring consumables, software-enabled workflows, market access, and enterprise contracts.
GE HealthCare earns revenue from products and services sold to healthcare systems, clinicians, payers, labs, pharmacies, governments, distributors, life-science customers, or patients depending on the business line. In 2025, that model produced $20.6B 2025 of reported revenue scale. Growth is tied to product demand, procedure or test volumes, prescription access, installed-base utilization, new indications, geographic reach, and disciplined pricing.
Pricing is not a public self-serve tier. It is negotiated by therapy, device, test, payer coverage, account type, contract term, service level, GPO or distributor structure, reimbursement, and geography. The practical tiers are enterprise account segmentation, clinical evidence review, value-analysis committee approval, data/security review, legal terms, and renewal or tender economics.
Vendors should expect mature procurement and high evidence requirements. Budgets open when a proposal helps GE HealthCare improve launch execution, manufacturing resilience, clinical operations, data quality, regulatory readiness, patient access, field productivity, cybersecurity, or cost-to-serve.
Who leads GE HealthCare?
GE HealthCare is led by Peter Arduini, with finance, R&D, commercial, technology, medical, operations, and business-unit leaders shaping major enterprise decisions.
- Peter ArduiniPresident and Chief Executive OfficerCEO since GE HealthCare spin-offLeads imaging, diagnostics, monitoring, and digital growth.
- Jay SaccaroVice President and Chief Financial OfficerCFO since 2023Oversees finance and public-company execution.
- Roland RottPresident and CEO, ImagingBusiness-unit leaderRuns GE HealthCare's largest imaging franchise.
- Phil RackliffePresident and CEO, Ultrasound and IGTBusiness-unit leaderLeads ultrasound and image-guided therapies.
How do you contact GE HealthCare's leadership?
GE HealthCare publishes official GE HealthCare investor-relations contact route, but it does not publish verified personal executive emails for the leaders listed here. Use the official investor, media, supplier, compliance, or contact form routes rather than guessed personal addresses.
official GE HealthCare investor-relations contact route; personal executive email format not verified- Peter ArduiniPresident and Chief Executive Officerofficial GE HealthCare investor-relations contact route
- Jay SaccaroVice President and Chief Financial Officerofficial GE HealthCare investor-relations contact route
How much funding has GE HealthCare raised?
GE HealthCare is a mature public company, not a venture-backed startup. It trades as Nasdaq: GEHC and funds growth through operating cash flow, public-market access, debt markets, partnerships, and acquisition capacity.
GE HealthCare's capital history is a public-company story rather than a disclosed venture-round history. The relevant funding events are founding, public listing, major acquisitions or divestitures, retained earnings, debt capacity, R&D reinvestment, manufacturing investment, and shareholder capital allocation.
As of June 2026, the current capital lens is Nasdaq: GEHC, $20.6B 2025 of 2025 revenue scale, and management's ability to fund launches, facilities, technology, clinical programs, supply chain, compliance, and business development. That is materially different from a startup where the next round controls hiring and tool budgets.
Seller signal: GE HealthCare has enterprise buying power, but budget access is tied to risk, ROI, auditability, executive sponsorship, and integration fit. Procurement is more likely to approve projects that reduce operational friction, protect regulated workflows, improve patient or customer outcomes, or support a named business priority.
How did GE HealthCare get here?
GE HealthCare grew through founding, product expansion, public-market scale, strategic portfolio moves, and regulated healthcare execution.
- 1890sGE healthcare rootsGE's medical technology business traces back through X-ray and imaging innovation.
- 2023GE HealthCare spin-offGE HealthCare becomes an independent public company.
- 2024MIM Software acquisitionGE HealthCare expands imaging software and oncology workflow capabilities.
- 2025$20.6B revenueGE HealthCare reports 2025 revenue of $20.6 billion.
- 2026Q1 growthQ1 2026 revenue rises to $5.13 billion.
- 2026Installed base scaleThe company reports roughly 5 million units installed globally.
Who are GE HealthCare's competitors?
GE HealthCare competes with large healthcare, pharma, diagnostics, life-science, and medtech companies that overlap in products, customers, procurement budgets, and clinical workflows.
- Siemens HealthineersCompetes in imaging, diagnostics, oncology care, and hospital technology.
- PhilipsCompetes in imaging, monitoring, ultrasound, and connected care.
- Canon MedicalCompetes in CT, MRI, ultrasound, and imaging systems.
- Fujifilm HealthcareCompetes in imaging, informatics, endoscopy-adjacent systems, and diagnostics.
- MindrayCompetes in patient monitoring, ultrasound, and hospital equipment globally.
- HologicCompetes in women's health imaging and diagnostics.
GE HealthCare — frequently asked questions
